- Report
- April 2023
- 115 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- July 2023
- 140 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- January 2025
- 80 Pages
Saudi Arabia
From €3340EUR$3,500USD£2,799GBP
- Report
- February 2024
- 125 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- March 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- February 2024
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- September 2020
- 84 Pages
Global
From €3818EUR$4,000USD£3,199GBP
- Report
- August 2024
- 82 Pages
Japan
From €3340EUR$3,500USD£2,799GBP
- Report
- November 2023
- 140 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- September 2021
- 189 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- August 2020
- 86 Pages
Europe
From €3293EUR$3,450USD£2,759GBP
- Report
- August 2023
- 145 Pages
Global
From €3006EUR$3,150USD£2,519GBP
- Report
- January 2023
- 293 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- January 2024
- 244 Pages
Global
€4767EUR$4,995USD£3,994GBP
- Clinical Trials
- September 2018
- 700 Pages
Global
From €2863EUR$3,000USD£2,399GBP
- Training
- 75 Minutes
Global
- Training
- 60 Minutes
Global
- Book
- March 2021
- 320 Pages

Early Phase Studies are a critical part of the drug discovery process. They are the first step in the clinical development of a drug, and involve the testing of a drug's safety, efficacy, and pharmacokinetics in humans. Early Phase Studies are typically conducted in small groups of healthy volunteers or patients, and involve the administration of a single dose or multiple doses of the drug. The results of these studies are used to determine whether the drug is safe and effective for further clinical development.
Early Phase Studies are conducted by a variety of companies, including contract research organizations (CROs), pharmaceutical companies, and biotechnology companies. These companies provide services such as clinical trial design, data management, and regulatory support. They also provide expertise in drug development, clinical trial management, and regulatory compliance.
Some of the companies in the Early Phase Study market include Parexel, Quintiles, Covance, PPD, ICON, and Syneos Health. Show Less Read more